trial

Improving Insight in Patients Diagnosed With Schizophrenia

NCTId NCT01282307
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 101 (actual)
Sponsored by University of Aarhus
Primary completion 2012-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
101 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2008-02
Primary completion
2012-07
Eligibility
ALL · 18 Years · 70 Years

Interventions & indications

Drugs
Guided Self-Determination GSD

Sponsors

University of AarhusLead Sponsor
Aalborg Psychiatric HospitalCollaborator

Investigators

1
Rikke Jørgensen, MSNPrincipal Investigator

Sites

1 total
Aalborg, Denmark

Facts & assertions

4 sourced
Enrollment
101
Phase
NA
Primary Completion Date
2012-07
Status
COMPLETED
relationships
The graph out of here
drug
Guided Self-Determination GSD
drug
lead_sponsor
University of Aarhus
company
collaborator
Aalborg Psychiatric Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Rikke Jørgensen, MSN
person